Download
11060_2024_Article_4780.pdf 891,45KB
WeightNameValue
1000 Titel
  • Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of age
1000 Autor/in
  1. Schwartz, Christoph |
  2. Ueberschaer, Moritz F. |
  3. Rautalin, Ilari |
  4. Grauvogel, Jürgen |
  5. Bissolo, Marco |
  6. Masalha, Waseem |
  7. Steiert, Christine |
  8. Schnell, Oliver |
  9. Beck, Jürgen |
  10. Ebel, Florian |
  11. Bervini, David |
  12. Raabe, Andreas |
  13. Eibl, Thomas |
  14. Steiner, Hans-Herbert |
  15. Schebesch, Karl-Michael |
  16. Shlobin, Nathan A. |
  17. Nandoliya, Khizar R. |
  18. Youngblood, Mark W. |
  19. Chandler, James P. |
  20. Magill, Stephen T. |
  21. Romagna, Alexander |
  22. Lehmberg, Jens |
  23. Fuetsch, Manuel |
  24. Spears, Julian |
  25. Rezai, Arwin |
  26. Ladisich, Barbara |
  27. Demetz, Matthias |
  28. Griessenauer, Christoph J. |
  29. Niemelä, Mika |
  30. Korja, Miikka |
1000 Verlag Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-09-04
1000 Erschienen in
1000 Quellenangabe
  • 170(1):89-100
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11060-024-04780-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447097/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To assess whether the Modified 5 (mFI-5) and 11 (mFI-11) Factor Frailty Indices associate with postoperative mortality, complications, and functional benefit in supratentorial meningioma patients aged over 80 years.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Baseline characteristics were collected from eight centers. Based on the patients’ preoperative status and comorbidities, frailty was assessed by the mFI-5 and mFI-11. The collected scores were categorized as “robust (mFI=0)”, “pre-frail (mFI=1)”, “frail (mFI=2)”, and “significantly frail (mFI≥3)”. Outcome was assessed by the Karnofsky Performance Scale (KPS); functional benefit was defined as improved KPS score. Additionally, we evaluated the patients’ functional independence (KPS≥70) after surgery.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The study population consisted of 262 patients (median age 83 years) with a median preoperative KPS of 70 (range 20 to 100). The 90-day and 1-year mortality were 9.0% and 13.2%; we recorded surgery-associated complications in 111 (42.4%) patients. At last follow-up within the postoperative first year, 101 (38.5%) patients showed an improved KPS, and 183 (69.8%) either gained or maintained functional independence. “Severely frail” patients were at an increased risk of death at 90 days (OR 16.3 (CI95% 1.7-158.7)) and one year (OR 11.7 (CI95% 1.9-71.7)); nine (42.9%) of severely frail patients died within the first year after surgery. The “severely frail” cohort had increased odds of suffering from surgery-associated complications (OR 3.9 (CI 95%) 1.3-11.3)), but also had a high chance for postoperative functional improvements by KPS≥20 (OR 6.6 (CI95% 1.2-36.2)).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>The mFI-5 and mFI-11 associate with postoperative mortality, complications, and functional benefit. Even though “severely frail” patients had the highest risk morbidity and mortality, they had the highest chance for functional improvement.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Aged, 80 and over [MeSH]
lokal Supratentorial Neoplasms/surgery [MeSH]
lokal Postoperative Complications/mortality [MeSH]
lokal Frail Elderly [MeSH]
lokal Frailty/complications [MeSH]
lokal Postoperative Complications/epidemiology [MeSH]
lokal Meningeal Neoplasms/surgery [MeSH]
lokal Mortality
lokal Male [MeSH]
lokal Meningioma/surgery [MeSH]
lokal Modified 5 (mFI-5) and 11 (mFI-11) Factor Frailty Indices
lokal Meningioma
lokal Meningeal Neoplasms/mortality [MeSH]
lokal Karnofsky Performance Status [MeSH]
lokal Female [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Functional outcome
lokal Elderly
lokal Humans [MeSH]
lokal Meningioma/mortality [MeSH]
lokal Retrospective Studies [MeSH]
lokal Frailty/mortality [MeSH]
lokal Research
lokal Prognosis [MeSH]
lokal Supratentorial Neoplasms/mortality [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2Nod2FydHosIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/VWViZXJzY2hhZXIsIE1vcml0eiBGLg==|https://frl.publisso.de/adhoc/uri/UmF1dGFsaW4sIElsYXJp|https://frl.publisso.de/adhoc/uri/R3JhdXZvZ2VsLCBKw7xyZ2Vu|https://frl.publisso.de/adhoc/uri/Qmlzc29sbywgTWFyY28=|https://frl.publisso.de/adhoc/uri/TWFzYWxoYSwgV2FzZWVt|https://frl.publisso.de/adhoc/uri/U3RlaWVydCwgQ2hyaXN0aW5l|https://frl.publisso.de/adhoc/uri/U2NobmVsbCwgT2xpdmVy|https://frl.publisso.de/adhoc/uri/QmVjaywgSsO8cmdlbg==|https://frl.publisso.de/adhoc/uri/RWJlbCwgRmxvcmlhbg==|https://frl.publisso.de/adhoc/uri/QmVydmluaSwgRGF2aWQ=|https://frl.publisso.de/adhoc/uri/UmFhYmUsIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/RWlibCwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/U3RlaW5lciwgSGFucy1IZXJiZXJ0|https://frl.publisso.de/adhoc/uri/U2NoZWJlc2NoLCBLYXJsLU1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/U2hsb2JpbiwgTmF0aGFuIEEu|https://frl.publisso.de/adhoc/uri/TmFuZG9saXlhLCBLaGl6YXIgUi4=|https://frl.publisso.de/adhoc/uri/WW91bmdibG9vZCwgTWFyayBXLg==|https://frl.publisso.de/adhoc/uri/Q2hhbmRsZXIsIEphbWVzIFAu|https://frl.publisso.de/adhoc/uri/TWFnaWxsLCBTdGVwaGVuIFQu|https://frl.publisso.de/adhoc/uri/Um9tYWduYSwgQWxleGFuZGVy|https://frl.publisso.de/adhoc/uri/TGVobWJlcmcsIEplbnM=|https://frl.publisso.de/adhoc/uri/RnVldHNjaCwgTWFudWVs|https://frl.publisso.de/adhoc/uri/U3BlYXJzLCBKdWxpYW4=|https://frl.publisso.de/adhoc/uri/UmV6YWksIEFyd2lu|https://frl.publisso.de/adhoc/uri/TGFkaXNpY2gsIEJhcmJhcmE=|https://frl.publisso.de/adhoc/uri/RGVtZXR6LCBNYXR0aGlhcw==|https://frl.publisso.de/adhoc/uri/R3JpZXNzZW5hdWVyLCBDaHJpc3RvcGggSi4=|https://frl.publisso.de/adhoc/uri/TmllbWVsw6QsIE1pa2E=|https://frl.publisso.de/adhoc/uri/S29yamEsIE1paWtrYQ==
1000 Hinweis
  • DeepGreen-ID: 29f273f6bffe47a4b2293432c215ae3d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Paracelsus Medizinische Privatuniversität |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Paracelsus Medizinische Privatuniversität |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6495163.rdf
1000 Erstellt am 2025-02-04T07:21:15.016+0100
1000 Erstellt von 322
1000 beschreibt frl:6495163
1000 Zuletzt bearbeitet 2025-08-05T07:19:14.263+0200
1000 Objekt bearb. Tue Aug 05 07:19:14 CEST 2025
1000 Vgl. frl:6495163
1000 Oai Id
  1. oai:frl.publisso.de:frl:6495163 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source